Schaffer David's Form 4 filing
4D Molecular Therapeutics, Inc. (FDMT) · filed Oct 1, 2021
- Accession no.
- 0001567619-21-017751
- Filed
- Oct 1, 2021
- Trade date
- Sep 29-30, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $815.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schaffer DavidCIK 0001692929 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2021 | Common Stock | SSaleDisposed | −7,806 | $27.99 | −$218,489.94 | 958,950 | Direct | |
| Sep 29, 2021 | Common Stock | SSaleDisposed | −8,365 | $29.06 | −$243,086.9 | 950,585 | Direct | |
| Sep 29, 2021 | Common Stock | SSaleDisposed | −700 | $30.06 | −$21,042 | 949,885 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −7,836 | $26.69 | −$209,142.84 | 942,049 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −4,549 | $27.28 | −$124,096.72 | 937,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.